NCT01585077View on ClinicalTrials.gov

Exposure of Naive and Pre-immune Subjects to P. Vivax Challenge

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

November 30, 2013

Conditions
Malaria
Interventions
BIOLOGICAL

P. vivax infected mosquito bites

All volunteers will receive one dose of 2-4 P. vivax infected mosquito bites. All the mosquitoes will correspond to the same mosquito batch to make sure that all volunteers receive the same P. vivax strain.

Trial Locations (1)

Unknown

Malaria Vaccine and Drug development Center (MVDC), Santiago de Cali

All Listed Sponsors
lead

Socrates Herrera Valencia

OTHER

NCT01585077 - Exposure of Naive and Pre-immune Subjects to P. Vivax Challenge | Biotech Hunter | Biotech Hunter